Myositis associated with griseofulvin therapy.
Davidson
B K
BK
D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects*; D006118:Griseofulvin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009220:Myositis / Q000139:chemically induced*; D014006:Tinea Capitis / Q000188:drug therapy
D000935:Antifungal Agents; D006118:Griseofulvin